Sep 29

QP 25 - Clinical Potpourri: Navigating Early-Stage RT, N1mi Disease, and Risk Mitigation in Triple Negative and HER2+ Breast Cancer

1149 - Post-Mastectomy Radiotherapy in pT1-2N1 HER2-Enriched Breast Cancer: Reassessing Its Role in the Anti-HER2 Era

05:25pm - 05:30pm ET

Presenter(s)

Xiaofang Wang, PhD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai